from Reuters: Health News https://ift.tt/2IpYF0l
Merck KGaA's lung cancer drugs show promise in early-stage trials
FRANKFURT (Reuters) - Germany's Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients, potentially helping the company's efforts to find drug-industry partners to share further development costs.
from Reuters: Health News https://ift.tt/2IpYF0l
from Reuters: Health News https://ift.tt/2IpYF0l
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment